VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study.

(2017) R. A. Burger et al.   JOURNAL OF CLINICAL ONCOLOGY

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer

(2011) Maurie Markman   GYNECOLOGIC ONCOLOGY

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2

(2011) Apostolos C. Ziogas et al.   INTERNATIONAL JOURNAL OF CANCER

VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer

(2010) Maximilian J. Waldner et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Tumor Immune Evasion

(2010) C. L. Zindl et al.   SCIENCE

Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells

(2009) Jin-Young Shin et al.   CELLULAR IMMUNOLOGY

VEGFR2 is selectively expressed by FOXP3high CD4+ Treg

(2009) Hiroyuki Suzuki et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Hypoxia but not cigarette smoke modulates VEGF secretion from human T cells

(2009) Mikael Mikko et al.   GROWTH FACTORS

Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo

(2009) Sylvianna Georgaki et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+ CD4+ T Cells Promotes Akt and ERK Activation and Costimulates IFN-  Production

(2009) A. Basu et al.   JOURNAL OF IMMUNOLOGY

The Role of VEGF Pathways in Human Physiologic and Pathologic Angiogenesis

(2009) John M. Lyons et al.   JOURNAL OF SURGICAL RESEARCH

The role of microenvironment in tumor angiogenesis

(2008) Domenico Ribatti et al.   Genes and Nutrition

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy

(2007) Aristotelis Bamias et al.   GYNECOLOGIC ONCOLOGY